Recombinant Human Uncharacterized protein ATPAF1-AS1 (ATPAF1-AS1)

What is ATPAF1-AS1 and how does it relate to ATPAF1?

ATPAF1-AS1 is an antisense RNA that is transcribed from the opposite strand of the ATPAF1 gene locus. While ATPAF1 encodes the ATP synthase mitochondrial F1 complex assembly factor 1, which is essential for the proper assembly of the F1 component of mitochondrial ATP synthase , ATPAF1-AS1 is a non-coding RNA that may potentially regulate ATPAF1 expression through various mechanisms.

Antisense RNAs typically function by binding to their sense counterparts, potentially affecting their stability, translation, or processing. Methodologically, researchers should approach ATPAF1-AS1 by first examining its expression patterns in relation to ATPAF1 across different tissues and under various physiological conditions, employing techniques such as quantitative RT-PCR, RNA-seq, and in situ hybridization.

What is known about the expression patterns of ATPAF1 that might inform ATPAF1-AS1 research?

ATPAF1 shows nearly constant expression across various tissues in both adult and developing mice (5-day-old), suggesting ubiquitous importance . This widespread expression pattern suggests that ATPAF1-AS1 may also be expressed in multiple tissues, though potentially with tissue-specific regulation patterns.

To study ATPAF1-AS1 expression in relation to ATPAF1, researchers should:

• Perform parallel quantitative RT-PCR analyses of both transcripts across tissue panels

• Analyze publicly available RNA-seq datasets for co-expression patterns

• Investigate potential inverse expression relationships that might suggest regulatory functions

• Examine expression under conditions known to affect mitochondrial function or ATP synthesis

What are the known cellular functions of ATPAF1 that might suggest potential roles for ATPAF1-AS1?

ATPAF1 serves as a crucial assembly factor for the F1 component of mitochondrial ATP synthase. It specifically binds to the F1 beta subunit, preventing the formation of nonproductive homooligomers during enzyme assembly . Knockout studies in mice have demonstrated that ATPAF1 deficiency leads to:

• Decreased ATP synthase content and function

• Mitochondrial ultrastructural abnormalities including condensed degenerated mitochondria and loss of cristae

• Impaired respiratory capacity

• Cardiac dysfunction with left ventricle hypertrophy and remodeling

ATPAF1-AS1 might therefore play a role in regulating these processes by modulating ATPAF1 expression, particularly under stress conditions or during developmental stages with high energy demands.

What experimental approaches would be most effective for characterizing the function of ATPAF1-AS1?

For characterizing ATPAF1-AS1 function, a multi-faceted approach is recommended:

• Knockdown/Overexpression Studies:

  • Use siRNA or antisense oligonucleotides targeting ATPAF1-AS1

  • Create CRISPR/Cas9-mediated knockout cell lines

  • Engineer inducible expression systems for controlled ATPAF1-AS1 overexpression

• Interaction Analysis:

  • RNA immunoprecipitation (RIP) to identify protein partners

  • RNA pull-down assays followed by mass spectrometry

  • CHART (Capture Hybridization Analysis of RNA Targets) to identify genomic binding sites

• Functional Impact Assessment:

  • Measure ATPAF1 mRNA and protein levels following ATPAF1-AS1 modulation

  • Assess ATP synthase assembly using Blue-Native electrophoresis (BN-PAGE)

  • Evaluate mitochondrial function parameters:

    • Oxygen consumption rate

    • ATP production

    • Mitochondrial membrane potential

    • Mitochondrial morphology

• Tissue-Specific Analysis:

  • Focus particularly on heart tissue, given the established importance of ATPAF1 in cardiac function

  • Compare high-energy demanding tissues with those having lower energy requirements

How might ATPAF1-AS1 potentially impact mitochondrial ATP synthase assembly and function?

Based on the established role of ATPAF1, ATPAF1-AS1 could influence ATP synthase assembly and function through several mechanisms:

• Transcriptional Regulation: ATPAF1-AS1 might modulate ATPAF1 expression by interfering with transcription factor binding or recruiting chromatin modifiers to the ATPAF1 locus.

• Post-transcriptional Regulation: ATPAF1-AS1 could influence ATPAF1 mRNA stability, splicing, or nuclear export.

• Translational Control: By binding to ATPAF1 mRNA, ATPAF1-AS1 might inhibit or enhance translation.

• Indirect Pathways: ATPAF1-AS1 might regulate other factors involved in mitochondrial biogenesis or ATP synthase assembly.

Experimental approaches to investigate these possibilities should include:

• RNA-protein complex immunoprecipitation to identify ATPAF1-AS1 binding partners

• Polysome profiling to assess translational impacts

• In-gel ATPase activity assays following ATPAF1-AS1 modulation, similar to methods used for ATPAF1 studies

What is the potential relationship between ATPAF1-AS1 and disease states associated with mitochondrial dysfunction?

Given that ATPAF1 deficiency leads to cardiac dysfunction in mouse models and mitochondrial ATP synthase deficiencies are associated with various human diseases, ATPAF1-AS1 could potentially play a role in:

• Cardiomyopathies: The established link between ATPAF1 and cardiac function suggests ATPAF1-AS1 dysregulation might contribute to heart failure or cardiomyopathies.

• Neurodegenerative Disorders: ATP synthase deficiencies are associated with conditions like Leigh syndrome , suggesting potential ATPAF1-AS1 involvement in neurological disorders.

• Metabolic Diseases: Given the central role of ATP production in metabolism, ATPAF1-AS1 might influence metabolic disorders.

• Aging-Related Pathologies: Mitochondrial dysfunction is a hallmark of aging, making ATPAF1-AS1 a potential factor in age-related decline.

Methodological approaches should include:

• Analysis of ATPAF1-AS1 expression in patient-derived tissues

• Correlation studies between ATPAF1-AS1 expression levels and disease severity

• Development of disease models with altered ATPAF1-AS1 expression

What are the optimal methods for producing recombinant ATPAF1-AS1 for research applications?

For producing recombinant ATPAF1-AS1:

• In vitro Transcription:

  • Clone ATPAF1-AS1 sequence downstream of a T7 or SP6 promoter

  • Perform in vitro transcription with appropriate RNA polymerase

  • Purify using gel electrophoresis or commercial RNA purification kits

  • Consider incorporating modified nucleotides for stability if needed

• Expression in Bacterial Systems:

  • For studies requiring large amounts of ATPAF1-AS1

  • Clone into expression vectors with inducible promoters

  • Express in appropriate bacterial strains (e.g., Rosetta for rare codon optimization)

  • Perform RNA extraction under conditions that minimize RNase activity

• Quality Control:

  • Verify size and integrity by denaturing gel electrophoresis

  • Confirm sequence by reverse transcription and sequencing

  • Assess purity by spectrophotometric analysis (A260/A280 ratio)

• Storage and Handling:

  • Store in RNase-free conditions with RNase inhibitors

  • Aliquot to avoid freeze-thaw cycles

  • Consider addition of carrier RNA for dilute solutions

What detection and quantification methods are most suitable for ATPAF1-AS1 in experimental settings?

For detecting and quantifying ATPAF1-AS1 in experimental settings:

• Quantitative RT-PCR:

  • Design strand-specific primers that distinguish ATPAF1-AS1 from ATPAF1 mRNA

  • Implement strict controls for specificity validation

  • Use appropriate reference genes for normalization

• Northern Blotting:

  • Provides size information and specificity

  • Design probes specifically targeting ATPAF1-AS1

  • Include controls to verify strand specificity

• RNA Fluorescence In Situ Hybridization (RNA-FISH):

  • For visualizing subcellular localization

  • Design probes that specifically recognize ATPAF1-AS1

  • Combine with immunofluorescence for co-localization studies

• RNA-Seq:

  • Implement strand-specific library preparation protocols

  • Apply computational pipelines optimized for antisense transcript detection

  • Validate findings with other methods due to potential mapping ambiguities

How should researchers design experiments to study potential regulatory interactions between ATPAF1-AS1 and ATPAF1?

To investigate regulatory interactions between ATPAF1-AS1 and ATPAF1:

• Expression Correlation Analysis:

  • Measure both transcripts across:

    • Different cell types and tissues

    • Developmental stages

    • Stress conditions (especially mitochondrial stress)

  • Look for inverse correlation patterns suggestive of regulatory relationships

• Direct Interaction Studies:

  • Perform RNA-RNA interaction assays (e.g., RNA antisense purification)

  • Use tagged RNA molecules to pull down potential complexes

  • Implement cross-linking methods to capture transient interactions

• Functional Impact Assessment:

  • Modulate ATPAF1-AS1 levels and monitor effects on:

    • ATPAF1 mRNA levels and stability

    • ATPAF1 protein expression

    • ATP synthase assembly (using BN-PAGE as in ATPAF1 studies )

    • Mitochondrial function parameters

• Mechanism Exploration:

  • Investigate chromatin modifications at the ATPAF1 locus following ATPAF1-AS1 manipulation

  • Examine recruitment of regulatory proteins to the ATPAF1/ATPAF1-AS1 genomic region

  • Assess potential impacts on ATPAF1 mRNA processing, export, and translation

What animal models would be most appropriate for studying ATPAF1-AS1 function in vivo?

Based on the known importance of ATPAF1 in cardiac function and development , the following animal models would be appropriate:

• Mouse Models:

  • CRISPR/Cas9-generated ATPAF1-AS1 knockout mice

  • Conditional knockout models using tissue-specific promoters

  • Transgenic overexpression models

  • Consider cardiac-specific manipulations given the established importance of ATPAF1 in heart function

• Experimental Approaches:

  • Echocardiography to assess cardiac function

  • Mitochondrial isolation and respiratory capacity measurements

  • Blue-Native PAGE for ATP synthase assembly analysis

  • Electron microscopy for mitochondrial ultrastructure examination

• Developmental Studies:

  • Examine embryonic lethality patterns (noting that ATPAF2-KO was embryonically lethal while ATPAF1-KO mice survived to adulthood but with smaller body sizes )

  • Investigate tissue-specific expression patterns during development

  • Study compensatory mechanisms in ATPAF1-AS1 knockout models

• Disease Models:

  • Cardiac stress models (e.g., pressure overload, ischemia-reperfusion)

  • Metabolic challenge models (e.g., high-fat diet)

  • Aging studies to assess long-term effects

What are the most promising avenues for future research on ATPAF1-AS1?

Future research on ATPAF1-AS1 should focus on:

• Comprehensive Expression Profiling:

  • Create a detailed atlas of ATPAF1-AS1 expression across tissues, developmental stages, and disease states

  • Compare with ATPAF1 expression patterns to identify potential regulatory relationships

  • Investigate subcellular localization patterns

• Functional Characterization:

  • Determine the impact of ATPAF1-AS1 on ATPAF1 expression and function

  • Investigate effects on ATP synthase assembly and activity

  • Explore broader impacts on mitochondrial function and cellular energy metabolism

• Mechanistic Studies:

  • Identify protein binding partners of ATPAF1-AS1

  • Determine the structural features of ATPAF1-AS1 critical for its function

  • Investigate epigenetic regulation of the ATPAF1/ATPAF1-AS1 locus

• Therapeutic Potential:

  • Explore ATPAF1-AS1 as a potential target for disorders involving mitochondrial dysfunction

  • Investigate therapeutic approaches for modulating ATPAF1-AS1 expression or function

  • Develop biomarkers based on ATPAF1-AS1 expression for mitochondrial diseases

How might high-throughput technologies advance our understanding of ATPAF1-AS1?

High-throughput technologies offer several approaches to advance ATPAF1-AS1 research:

• Single-Cell RNA-Seq:

  • Reveal cell-type specific expression patterns

  • Identify potential regulatory relationships at single-cell resolution

  • Discover rare cell populations with unique ATPAF1-AS1 expression patterns

• CRISPR Screening:

  • Perform genome-wide CRISPR screens to identify factors affecting ATPAF1-AS1 expression

  • Screen for genes whose disruption creates synthetic lethality with ATPAF1-AS1 modulation

  • Identify regulatory elements controlling ATPAF1-AS1 expression

• Proteomics Approaches:

  • Identify proteins interacting with ATPAF1-AS1 using RNA-protein interaction screens

  • Analyze changes in the mitochondrial proteome following ATPAF1-AS1 manipulation

  • Study post-translational modifications affected by ATPAF1-AS1 expression

• Structural Biology:

  • Determine the secondary and tertiary structure of ATPAF1-AS1

  • Characterize structural features important for function

  • Visualize potential ATPAF1-AS1:ATPAF1 mRNA interactions